» Articles » PMID: 19898742

Cerebral Amyloidosis: Amyloid Subunits, Mutants and Phenotypes

Overview
Publisher Springer
Specialty Biology
Date 2009 Nov 10
PMID 19898742
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral amyloid diseases are part of a complex group of chronic and progressive entities bracketed together under the common denomination of protein folding disorders and characterized by the intra- and extracellular accumulation of fibrillar aggregates. Of the more than 25 unrelated proteins known to produce amyloidosis in humans only about a third of them are associated with cerebral deposits translating in cognitive deficits, dementia, stroke, cerebellar and extrapyramidal signs, or a combination thereof. The familial forms reviewed herein, although infrequent, provide unique paradigms to examine the role of amyloid in the mechanism of disease pathogenesis and to dissect the link between vascular and parenchymal amyloid deposition and their differential contribution to neurodegeneration.

Citing Articles

Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.

Zheng W, Lin D, Shi S, Ren J, Wu J, Wang M J Alzheimers Dis Rep. 2025; 8(1):1558-1572.

PMID: 40034343 PMC: 11863729. DOI: 10.1177/25424823241289804.


Identification of immune infiltration and PANoptosis-related molecular clusters and predictive model in Alzheimer's disease based on transcriptome analysis.

Mei J, Wang S, Zhao Y, Xu T, Luo Y, Xiong L Ibrain. 2024; 10(3):323-344.

PMID: 39346794 PMC: 11427814. DOI: 10.1002/ibra.12179.


Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease.

Pantelopulos G, Abraham C, Straub J Annu Rev Biophys. 2024; 53(1):455-486.

PMID: 38382114 PMC: 11575466. DOI: 10.1146/annurev-biophys-062823-023436.


Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases.

Ullah R, Lee E Exp Neurobiol. 2023; 32(4):216-246.

PMID: 37749925 PMC: 10569141. DOI: 10.5607/en23014.


Clinical considerations in early-onset cerebral amyloid angiopathy.

Banerjee G, Collinge J, Fox N, Lashley T, Mead S, Schott J Brain. 2023; 146(10):3991-4014.

PMID: 37280119 PMC: 10545523. DOI: 10.1093/brain/awad193.


References
1.
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B . A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992; 1(5):345-7. DOI: 10.1038/ng0892-345. View

2.
Davis J, Van Nostrand W . Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc Natl Acad Sci U S A. 1996; 93(7):2996-3000. PMC: 39749. DOI: 10.1073/pnas.93.7.2996. View

3.
Petersen R, Goren H, Cohen M, Richardson S, Tresser N, Lynn A . Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol. 1997; 41(3):307-13. DOI: 10.1002/ana.410410305. View

4.
Conway K, Harper J, Lansbury Jr P . Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry. 2000; 39(10):2552-63. DOI: 10.1021/bi991447r. View

5.
Levy E, Haltia M, KOIVUNEN O, Ghiso J, Prelli F, Frangione B . Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990; 172(6):1865-7. PMC: 2188742. DOI: 10.1084/jem.172.6.1865. View